Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Clinical trial NCT05701241 · RECRUITING

Trial details

NCT number: NCT05701241
Sponsor: University Hospital, Antwerp
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Gastroenteropancreatic Neuroendocrine Tumor

Start date: 2023-06-28
Primary completion: 2029-04-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.